AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 294: G1318-G1327, 2008. First published April 17, 2008; doi:10.1152/ajpgi.00025.2008
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/6/G1318    most recent
00025.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mizumori, M.
Right arrow Articles by Akiba, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizumori, M.
Right arrow Articles by Akiba, Y.

MUCOSAL BIOLOGY

CFTR inhibition augments NHE3 activity during luminal high CO2 exposure in rat duodenal mucosa

Misa Mizumori,2,4 Yuri Choi,5 Paul H. Guth,1 Eli Engel,3 Jonathan D. Kaunitz,1,2 and Yasutada Akiba2,4

1Greater Los Angeles Veterans Affairs Healthcare System; 2Department of Medicine, School of Medicine, 3Department of Biomathematics, University of California Los Angeles; 4Brentwood Biomedical Research Institute; and 5Harvard-Westlake School, Los Angeles, California

Submitted 18 January 2008 ; accepted in final form 12 April 2008

We hypothesized that the function of duodenocyte apical membrane acid-base transporters are essential for H+ absorption from the lumen. We thus examined the effect of inhibition of Na+/H+ exchanger-3 (NHE3), cystic fibrosis transmembrane regulator (CFTR), or apical anion exchangers on transmucosal CO2 diffusion and HCO3 secretion in rat duodenum. Duodena were perfused with a pH 6.4 high CO2 solution or pH 2.2 low CO2 solution with the NHE3 inhibitor, S3226, the anion transport inhibitor, DIDS, or pretreatment with the potent CFTR inhibitor, CFTRinh-172, with simultaneous measurements of luminal and portal venous (PV) pH and carbon dioxide concentration ([CO2]). Luminal high CO2 solution increased CO2 absorption and HCO3 secretion, accompanied by PV acidification and PV PCO2 increase. During CO2 challenge, CFTRinh-172 induced HCO3 absorption, while inhibiting PV acidification. S3226 reversed CFTRinh-associated HCO3 absorption. Luminal pH 2.2 challenge increased H+ and CO2 absorption and acidified the PV, inhibited by CFTRinh-172 and DIDS, but not by S3226. CFTR inhibition and DIDS reversed HCO3 secretion to absorption and inhibited PV acidification during CO2 challenge, suggesting that HCO3 secretion helps facilitate CO2/H+ absorption. Furthermore, CFTR inhibition prevented CO2-induced cellular acidification reversed by S3226. Reversal of increased HCO3 loss by NHE3 inhibition and reduced intracellular acidification during CFTR inhibition is consistent with activation or unmasking of NHE3 activity by CFTR inhibition, increasing cell surface H+ available to neutralize luminal HCO3 with consequent CO2 absorption. NHE3, by secreting H+ into the luminal microclimate, facilitates net transmucosal HCO3 absorption with a mechanism similar to proximal tubular HCO3 absorption.

CO2 absorption; bicarbonate secretion; portal venous PCO2



Address for reprint requests and other correspondence: J. Kaunitz, Bldg. 114, Ste. 217, West Los Angeles VA Medical Center, 11301 Wilshire Blvd., Los Angeles, CA 90073 (e-mail: jake{at}ucla.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.